Impaired aerobic exercise capacity and cardiac autonomic control in primary antiphospholipid syndrome

Abstract

Primary antiphospholipid syndrome (PAPS) is associated with increased risk of cardiovascular disease and mortality. Aerobic capacity and cardiac autonomic control are also associated with these risks. The aim of our study was to assess aerobic capacity and cardiac autonomic control in PAPS patients. Thirteen women with PAPS and 13 healthy controls matched for age, gender, and body mass index were enrolled for the study. Both groups were sedentary and were not under chronotropic, antidepressants and hypolipemiant drugs. All subjects performed a treadmill-graded maximal exercise. Aerobic capacity was assessed by peak oxygen uptake (VO(2)peak), time at anaerobic ventilatory threshold (VAT) and respiratory compensation point (RCP) and time-to-exhaustion, whereas cardiac autonomic control was assessed by chronotropic reserve (CR) and heart rate recovery at the first and second minutes after graded exercise (HRR1min and HRR2min, respectively). All aerobic capacity indexes were reduced more in PAPS patients than in healthy subjects: VO(2)peak (30.2 +/- 4.7 vs 34.6 +/- 4.3ml.kg(-1).min(-1), p=0.021), time at VAT (3.0 +/- 1.5 vs 5.0 +/- 2.0min, p=0.016), time at RCP (6.5 +/- 2.0 vs 8.0 +/- 2.0min, p=0.050), time-to-exhaustion (8.5 +/- 2.0 vs 11.0 +/- 2.5min, p=0.010). HRR1min (22 +/- 9 vs 30 +/- 7 bpm, p=0.032) and HRR2min (33 +/- 9 vs 46 +/- 8bpm, p=0.002) were delayed in PAPS patients compared to healthy controls but CR was not significantly different (p=0.272). In conclusion, an impaired aerobic capacity and cardiac autonomic control was identified in PAPS.